Vickaryous, NK, EM Teh, B. Stewart, PJ Dolphin, et al. 2003. "Deletion of N-terminal amino acids from human lecithin: cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins." Biochimica Et Biophysica Acta-Proteins and Proteomics 1646(1-2): 164-172.
Bishop, Jessica D., Wei Lun Nien, Shauna M. Dauphinee, and Catherine K. L. Too. 2006. "Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells." Journal of Endocrinology 190(2): 307-312.
Yadav, Yogesh, Erin D. MacLean, Annyt Bhattacharyya, Virinder S. Parmar, et al. 2011. "Design, synthesis and bioevaluation of novel candidate selective estrogen receptor modulators." European journal of medicinal chemistry 46(9): 3858-3866.
Boudreau, RTM, SM Sangster, LM Johnson, S. Dauphinee, et al. 2002. "Implication of alpha 4 phosphoprotein and the rapamycin-sensitive mammalian target-of-rapamycin pathway in prolactin receptor signalling." Journal of Endocrinology 173(3).
Too, CKL, N. Vickaryous, RTM Boudreau, and SM Sangster. 2001. "Identification and nuclear localization of a novel prolactin and cytokine-responsive carboxypeptidase D." Endocrinology 142(3): 1357-1367.
Dauphinee, SM, M. Ma, and CKL Too. 2005. "Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of Alpha4 phosphoprotein and Sp1 in rat lymphoma cells." Journal of cellular biochemistry 96(3): 579-588.
Johnson, LM, and CKL Too. 2001. "Prolactin, interleukin-2 and FGF-2 stimulate expression, nuclear distribution and DNA-binding of rat homolog of pombe Cdc5 in Nb2 T lymphoma cells." Molecular and cellular endocrinology 184(1-2): 151-161.
Too, CKL, R. Knee, AL Pinette, AW Li, et al. 1998. "Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54(nrb)-related mRNA in rat lymphoma cells." Molecular and cellular endocrinology 137(2): 187-195.
Too, CKL, C. Lee, SM Sangster, and PW Gout. 1999. "Malignant progression of rat Nb2 lymphoma cells: Chromosomal alterations and metastatic properties." Cancer genetics and cytogenetics 110(2): 115-123.
TOO, CKL, and DL GUERNSEY. 1992. "Increased Messenger-Rna Levels of the Antagonist Thyroid-Hormone Receptor Erba-Alpha-2 and Decreased Levels of Erba-Alpha-1 and Erba-Beta-1 Receptor Messenger-Rnas in Neoplastic Rodent Cells." Cancer research 52(8): 2186-2190.
Thomas, Lynn N., Timothy J. Morehouse, and Catherine K. L. Too. 2012. "Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells." Prostate 72(4): 450-460.
TOO, CKL, and DL GUERNSEY. 1993. "Elevation of the Thyroid-Hormone Receptor Erb A-Alpha-2 Messenger-Rna in Transformed Rodent Cells is due to Increased Message Stability." Cancer letters 70(3): 151-157.
TOO, CKL, and RP CROLL. 1995. "Detection of Fmrfamide-Like Immunoreactivities in the Sea Scallop Placopecten-Magellanicus by Immunohistochemistry and Western-Blot-Analysis." Cell and tissue research 281(2): 295-304.
Too, CKL. 1997. "Differential expression of elongation factor-2, alpha 4 phosphoprotein and Cdc5-like protein in prolactin-dependent/independent rat lymphoid cells." Molecular and cellular endocrinology 131(2): 221-232.
Too, CKL, A. Giles, and M. Wilkinson. 1999. "Estrogen stimulates expression of adenine nucleotide translocator ANT1 messenger RNA in female rat hearts." Molecular and cellular endocrinology 150(1-2): 161-167.